Background: A major cause of diarrheal illness mortality is a failure to seek immediate medical assistance. There is currently no evidence on the reasons that induce caregivers in Berbere Woreda to delayed seeking timely treatment for under-five children with diarrheal illnesses. As a result, the goal of this study was to identify determinants of delay in seeking timely treatment for childhood diarrheal diseases in Berbere Woreda, Bale Zone Oromia Region, South Eastern Ethiopia.
View Article and Find Full Text PDFBackground: Risk perception is a subjective psychological construct that is influenced by cognitive, emotional, social, cultural, and individual differences, both within and between individuals and across countries. Although the impact of COVID-19 on short- and long-term food security is difficult to predict, some risk factors and lessons from previous pandemics can be identified. The goal of this study is to assess rural farmers' perceptions of the COVID-19 pandemic's impact on crop production and its implications for food security in West Arsi Zone, Oromia, Ethiopia.
View Article and Find Full Text PDFBackground: Every year, large number of women are suffering from cervical cancer. Particularly women living with HIV are at high-risk of being suffered with it. Early testing of high-risk human papillomavirus infection can significantly reduce the incidence of cervical cancer.
View Article and Find Full Text PDFBackground: Access to outpatient therapeutic feeding programs (OTP) for all children who have uncomplicated severe acute malnutrition (SAM) remains a global public health priority. Identifying predictors that determine time-to-recovery from severe acute malnutrition optimize therapeutic success. However, reliable evidence on the determinants of time to recovery at health posts was not available in Nagele Arsi district of South Ethiopia.
View Article and Find Full Text PDFBackground: Late presentation for HIV/AIDS care is defined as individuals newly presenting for HIV/AIDS care with a CD4 count below 350 cells/μl or presenting for care with WHO clinical staging of stage III or IV. Globally, around 21.7 million people living with HIV/AIDS were receiving ART in 2017, with an increase of 2.
View Article and Find Full Text PDF